EGFR 타깃 프로그램 | 바이오정보모아

Data Tier

ADC · Antibody · CGT를 FDA 승인, ORR·PASI·ACR·BCVA, 임상 등록 규모, Phase 3, 조회수 등 공개 데이터로 복합 점수화합니다. S–C 티어와 가점 요인은 규칙 기반(Data Tier)이며 LLM이 아닙니다.

EGFR 타깃

Data Tier

프로그램 (49)

CART-EGFR-IL13Ra2 T cells (CART-EGFR-IL13Ra2 T cells)

anti-EGFR CAR T (anti-EGFR CAR T)

Dual-targeting VEGFR1 and PD-L1 CAR-T cells (Dual-targeting VEGFR1 and PD-L1 CAR-T cells)

EGFRt/19-28z/IL-12 CAR T-lymphocytes (EGFRt/19-28z/IL-12 CAR T-lymphocytes)

Erlotinib plus Bevacizumab (Erlotinib plus Bevacizumab)

Benmelstobart combined with Bevacizumab and chemotherapy (Benmelstobart combined with Bevacizumab and chemotherapy)

EGFR/HER2 Dual-Target CAR-NK Cells (EGFR/HER2 Dual-Target CAR-NK Cells)

IMGN289 (IMGN289)

Panitumumab or Cetuximab (Anti-EGFR, Anti-EGFR (Panitumumab or Cetuximab))

HWK-007 (HWK-007)

89Zr-Patritumab deruxtecan (89Zr-Patritumab deruxtecan)

EGFRvIII-CARs (EGFRvIII-CARs)

CART-EGFRvIII T cells (CART-EGFRvIII T cells)

SCRI-E2CAR_EGFRtv1 (SCRI-E2CAR_EGFRtv1)

EGFRt/BCMA-41BBz CAR T cell (EGFRt/BCMA-41BBz CAR T cell)

Metabolically Armed EGFRvIII CAR-T cells (Metabolically Armed EGFRvIII CAR-T cells)

Anti-VEGFR2 CAR CD8 plus PBL (Anti-VEGFR2 CAR CD8 plus PBL)

CART-EGFR (CART-EGFR)

3rd generation T cells (Patient Derived CD171 specific CAR T cells expressing EGFRt, Patient Derived CD171 specific CAR T cells expressing EGFRt (3rd generation T cells))

EGFR 타깃

Data Tier

프로그램 (49)

CART-EGFR-IL13Ra2 T cells (CART-EGFR-IL13Ra2 T cells)

anti-EGFR CAR T (anti-EGFR CAR T)

Dual-targeting VEGFR1 and PD-L1 CAR-T cells (Dual-targeting VEGFR1 and PD-L1 CAR-T cells)

EGFRt/19-28z/IL-12 CAR T-lymphocytes (EGFRt/19-28z/IL-12 CAR T-lymphocytes)

Erlotinib plus Bevacizumab (Erlotinib plus Bevacizumab)

Benmelstobart combined with Bevacizumab and chemotherapy (Benmelstobart combined with Bevacizumab and chemotherapy)

EGFR/HER2 Dual-Target CAR-NK Cells (EGFR/HER2 Dual-Target CAR-NK Cells)

IMGN289 (IMGN289)

Panitumumab or Cetuximab (Anti-EGFR, Anti-EGFR (Panitumumab or Cetuximab))

HWK-007 (HWK-007)

89Zr-Patritumab deruxtecan (89Zr-Patritumab deruxtecan)

EGFRvIII-CARs (EGFRvIII-CARs)

CART-EGFRvIII T cells (CART-EGFRvIII T cells)

SCRI-E2CAR_EGFRtv1 (SCRI-E2CAR_EGFRtv1)

EGFRt/BCMA-41BBz CAR T cell (EGFRt/BCMA-41BBz CAR T cell)

Metabolically Armed EGFRvIII CAR-T cells (Metabolically Armed EGFRvIII CAR-T cells)

Anti-VEGFR2 CAR CD8 plus PBL (Anti-VEGFR2 CAR CD8 plus PBL)

CART-EGFR (CART-EGFR)

3rd generation T cells (Patient Derived CD171 specific CAR T cells expressing EGFRt, Patient Derived CD171 specific CAR T cells expressing EGFRt (3rd generation T cells))

EGFR 타깃

Data Tier

프로그램 (49)

CART-EGFR-IL13Ra2 T cells (CART-EGFR-IL13Ra2 T cells)

anti-EGFR CAR T (anti-EGFR CAR T)

Dual-targeting VEGFR1 and PD-L1 CAR-T cells (Dual-targeting VEGFR1 and PD-L1 CAR-T cells)

EGFRt/19-28z/IL-12 CAR T-lymphocytes (EGFRt/19-28z/IL-12 CAR T-lymphocytes)

Erlotinib plus Bevacizumab (Erlotinib plus Bevacizumab)

Benmelstobart combined with Bevacizumab and chemotherapy (Benmelstobart combined with Bevacizumab and chemotherapy)

EGFR/HER2 Dual-Target CAR-NK Cells (EGFR/HER2 Dual-Target CAR-NK Cells)

IMGN289 (IMGN289)

Panitumumab or Cetuximab (Anti-EGFR, Anti-EGFR (Panitumumab or Cetuximab))

HWK-007 (HWK-007)

89Zr-Patritumab deruxtecan (89Zr-Patritumab deruxtecan)

EGFRvIII-CARs (EGFRvIII-CARs)

CART-EGFRvIII T cells (CART-EGFRvIII T cells)

SCRI-E2CAR_EGFRtv1 (SCRI-E2CAR_EGFRtv1)

EGFRt/BCMA-41BBz CAR T cell (EGFRt/BCMA-41BBz CAR T cell)

Metabolically Armed EGFRvIII CAR-T cells (Metabolically Armed EGFRvIII CAR-T cells)

Anti-VEGFR2 CAR CD8 plus PBL (Anti-VEGFR2 CAR CD8 plus PBL)

CART-EGFR (CART-EGFR)

3rd generation T cells (Patient Derived CD171 specific CAR T cells expressing EGFRt, Patient Derived CD171 specific CAR T cells expressing EGFRt (3rd generation T cells))